Premium
Implication of high‐body‐fat percentage on cardiometabolic risk in middle‐aged, healthy, normal‐weight adults
Author(s) -
Kim Ji Young,
Han SangHwan,
Yang BongMin
Publication year - 2013
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.20020
Subject(s) - medicine , dyslipidemia , abdominal obesity , odds ratio , confidence interval , body mass index , obesity , blood pressure , logistic regression , metabolic syndrome , endocrinology , gastroenterology
Objective This study investigated the number of Korean adults who had a normal body mass index (BMI) but high body‐fat percentage (BF%) and determined their increased risk factors for cardiovascular diseases, including high blood pressure, hyperglycemia, and dyslipidemia. Design and Methods This cross‐sectional study was based on 12,386 subjects (6,534 men and 5,852 women), with a normal BMI, between 30 and 49 years of age. Subjects were categorized into two groups by BF% (normal BF% group, BF% <25 for men, and BF% <30 for women; high BF(%) group, BF% ≥25 for men, and BF% ≥30 for women). Results The proportion of subjects with a normal BMI and high BF% was 12.7% ( n = 1,572; 291 [4.5%] men and 1,281 [21.9%] women). Subjects with a high BF% had a significantly higher prevalence of high blood pressure (men only), hyperglycemia, and dyslipidemia. Multiple logistic regression analyses revealed that subjects with a normal BMI and high BF% had a 1.63 (adjusted odds ratio, 95% confidence interval: 1.21–2.19) in men and 1.56 (adjusted odds ratio, 95% confidence interval: 1.36–1.80) in women increased risk of one or more cardiovascular risk factors compared to subjects in the normal BMI and normal BF% group, even after adjusting for abdominal obesity. Conclusion High BF% is associated with a high cardiometabolic risks, regardless of abdominal obesity, in normal‐weight Korean adults. Thus, follow‐up screening of those with a high BF% may be necessary to detect and prevent cardiometabolic diseases, particularly for women with a normal BMI.